Calcilytic NPS2143 promotes proliferation and inhibits apoptosis of spontaneously hypertensive rat vascular smooth muscle cells via activation of the renin‑angiotensin system

Zhao,Yongli; Tang,Na; Xi,Dongmei; Huang,Zhen; Zhang,Tian; Liu,Yongmin; Wang,Lamei; Tang,Yan; Zhong,Hua; He,Fang

doi:10.3892/etm.2020.8759

Calcilytic NPS2143 promotes proliferation and inhibits apoptosis of spontaneously hypertensive rat vascular smooth muscle cells via activation of the renin‑angiotensin system

Authors:
- Yongli Zhao
- Na Tang
- Dongmei Xi
- Zhen Huang
- Tian Zhang
- Yongmin Liu
- Lamei Wang
- Yan Tang
- Hua Zhong
- Fang He
View Affiliations

Affiliations: Department of Pathophysiology, Medical College of Shihezi University, Shihezi, Xinjiang 832002, P.R. China, The Centre of Medical Functional Experiments, Medical College of Shihezi University, Shihezi, Xinjiang 832002, P.R. China, Department of Geriatrics, The First Affiliated Hospital of Medical College of Shihezi University, Shihezi, Xinjiang 832002, P.R. China
Published online on: May 15, 2020 https://doi.org/10.3892/etm.2020.8759
Pages: 818-829
Copyright: © Zhao et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Vascular smooth muscle cell (VSMC) proliferation and apoptosis and the renin-angiotensin system (RAS) play critical roles in the development of essential hypertension. The activation of calcium‑sensing receptor (CaSR), functionally expressed in VSMCs, inhibits cyclic adenosine monophosphate (cAMP) formation by elevating intracellular calcium ([Ca2+]i) and then suppressing renin release. The present study aimed to investigate the effects of NPS2143‑mediated inhibition of CaSR on VSMC proliferation and apoptosis in spontaneously hypertensive rat (SHR) VSMCs and to assess whether these effects were mediated by alterations to RAS signaling. Primary VSMCs were isolated from the aortas of SHRs and Wistar‑Kyoto rats. SHR VSMCs were treated with CaSR antagonist NPS2143 and cell proliferation and CaSR and RAS‑related protein expression levels were measured to assess the effect. The results indicated that NPS2143 treatment promoted SHR VSMC proliferation, lower CaSR expression levels and higher RAS‑related proteins levels when compared with control treatment. Additional measurement of the expression levels of proteins related to proliferation, remodeling, apoptosis and RAS related proteins, as well as cell viability, cell cycle, cell apoptosis ratio, [Ca2+]i, and the concentration of cAMP was performed after treatment with NPS2143, PLC inhibitor U73122, IP3 receptor antagonist 2‑aminoethoxydiphenylborane (APB), adenylyl cyclase‑V inhibitor MDL12330A, angiotensin converting enzyme inhibitor captopril, angiotensin I receptor (AT1R) inhibitor losartan, NPS2143 + U73122, NPS2143 + 2‑APB, NPS2143 + MDL12330A, NPS2143 + captopril and NPS2143 + losartan. The results suggested that NPS2143 promoted cell proliferation, inhibited cell apoptosis, decreased [Ca2+]i and increased the expression of RAS compared with control treatments. NPS2143 + U73122 and NPS2143 + 2‑APB enhanced the effects of NPS2143, while NPS2143 + MDL12330A, NPS2143 + captopril, NPS2143 + losartan attenuated the effected of NPS2143 in SHR VSMCs. Furthermore, the knockdown of AT1R by AT1R‑short hairpin RNA also attenuated the effects of NPS2143 compared with NPS2143 alone. Collectively, these data indicated that NPS2143 promoted proliferation and inhibited apoptosis of VSMCs in SHRs, the effect of which was achieved by activation of RAS signaling.

View Figures

View References

1	Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK and He J: Global burden of hypertension: Analysis of worldwide data. Lancet. 365:217–223. 2005.PubMed/NCBI View Article : Google Scholar
2	Writing Group Members. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, Das SR, de Ferranti S, Després JP, et al: Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation. 133:e338–e360. 2016.PubMed/NCBI View Article : Google Scholar
3	Svetkey LP, Harris EL, Eden M, Vollmer WM, Meltesen GT, Ricchiuti V, Williams G, Appel LJ, Bray GA, Moore TJ, et al: Modulation of the BP response to diet by genes in the renin-angiotensin system and the adrenergic nervous system. Am J Hypertens. 24:209–217. 2011.PubMed/NCBI View Article : Google Scholar
4	Cai X: Regulation of smooth muscle cells in development and vascular disease: Current therapeutic strategies. Expert Rev Cardiovasc Ther. 4:789–800. 2006.PubMed/NCBI View Article : Google Scholar
5	Haudenschild CC, Grunwald J and Chobanian AV: Effects of hypertension on migration and proliferation of smooth muscle in culture. Hypertension. 7:I101–1104. 1985.PubMed/NCBI View Article : Google Scholar
6	Belo VA, Guimarães DA and Castro MM: Matrix metalloproteinase 2 as a potential mediator of vascular smooth muscle cell migration and chronic vascular remodeling in hypertension. J Vasc Res. 52:221–231. 2016.PubMed/NCBI View Article : Google Scholar
7	Bavishi C, Bangalore S and Messerli FH: Renin angiotensin aldosterone system inhibitors in hypertension: Is there evidence for benefit independent of blood pressure reduction? Prog Cardiovasc Dis. 59:253–261. 2016.PubMed/NCBI View Article : Google Scholar
8	Churchill PC: Second messengers in renin secretion. Am J Physiol. 249:175–184. 1985.PubMed/NCBI View Article : Google Scholar
9	Genest J, Nowaczynski W, Boucher R, Kuchel O and Rojo-Ortega JM: Aldosterone and renin in essential hypertension. Can Med Assoc J. 113:421–431. 1975.PubMed/NCBI
10	Touyz RM: The role of angiotensin II in regulating vascular structural and functional changes in hypertension. Curr Hypertens Rep. 5:155–164. 2003.PubMed/NCBI View Article : Google Scholar
11	Allender PS, Cutler JA, Follmann D, Cappuccio FP, Pryer J and Elliott P: Dietary calcium and blood pressure: A meta-analysis of randomized clinical trials. Ann Intern Med. 124:825–831. 1996.PubMed/NCBI View Article : Google Scholar
12	Atchison DK, Ortiz-Capisano MC and Beierwaltes WH: Acute activation of the calcium-sensing receptor inhibits plasma renin activity in vivo. Am J Physiol Regul Integr Comp Physiol. 299:R1020–R1026. 2010.PubMed/NCBI View Article : Google Scholar
13	Ayachi S: Increased dietary calcium lowers blood pressure in the spontaneously hypertensive rat. Metabolism. 28:1234–1238. 1979.PubMed/NCBI View Article : Google Scholar
14	Wang R, Xu C, Zhao W, Zhang J, Cao K, Yang B and Wu L: Calcium and polyamine regulated calcium-sensing receptors in cardiac tissues. Eur J Biochem. 270:2680–2688. 2003.PubMed/NCBI View Article : Google Scholar
15	Yamamura A, Yamamura H, Guo Q, Zimnicka AM, Wan J, Ko EA, Smith KA, Pohl NM, Song S, Zeifman A, et al: Dihydropyridine Ca(2+) channel blockers increase cytosolic [Ca(2+)] by activating Ca(2+)-sensing receptors in pulmonary arterial smooth muscle cells. Circ Res. 112:640–650. 2013.PubMed/NCBI View Article : Google Scholar
16	Guo J, Li HZ, Zhang WH, Wang LC, Wang LN, Zhang L, Li GW, Li HX, Yang BF, Wu L, et al: Increased expression of calcium-sensing receptors induced by ox-LDL amplifies apoptosis of cardiomyocytes during simulated ischaemia-reperfusion. Clin Exp Pharmacol Physiol. 37:e128–e135. 2010.PubMed/NCBI View Article : Google Scholar
17	Weston AH, Geraghty A, Egner I and Edwards G: The vascular extracellular calcium-sensing receptor: An update. Acta Physiol (Oxf). 203:127–137. 2011.PubMed/NCBI View Article : Google Scholar
18	Rybczynska A, Jurska-Jasko A, Boblewski K, Lehmann A and Orlewska C: Blockade of calcium channels and AT1 receptor prevents the hypertensive effect of calcilytic NPS 2143 in rats. J Physiol Pharmacol. 61:163–170. 2010.PubMed/NCBI
19	Rybczynska A, Lehmann A, Jurska-Jasko A, Boblewski K, Orlewska C, Foks H and Drewnowska K: Hypertensive effect of calcilytic NPS 2143 administration in rats. J Endocrinol. 191:189–195. 2006.PubMed/NCBI View Article : Google Scholar
20	Ogata H, Ritz E, Odoni G, Amann K and Orth SR: Beneficial effects of calcimimetics on progression of renal failure and cardiovascular risk factors. J Am Soc Nephrol. 14:959–967. 2003.PubMed/NCBI View Article : Google Scholar
21	Ortiz-Capisano MC, Reddy M, Mendez M, Garvin JL and Beierwaltes WH: Juxtaglomerular cell CaSR stimulation decreases renin release via activation of the PLC/IP(3) pathway and the ryanodine receptor. Am J Physiol Renal Physiol. 304:F248–F256. 2013.PubMed/NCBI View Article : Google Scholar
22	Qu YY, Hui J, Wang LM, Tang N, Zhong H, Liu YM, Li Z, Feng Q and He F: Reduced expression of the extracellular calcium-sensing receptor (CaSR) is associated with activation of the renin-angiotensin system (RAS) to promote vascular remodeling in the pathogenesis of essential hypertension. PLoS One. 11(e0157456)2016.PubMed/NCBI View Article : Google Scholar
23	Sun R, Zhang W, Zhong H, Wang L, Tang N, Liu Y, Zhao Y, Zhang T and He F: Calcimimetic R568 reduced the blood pressure and improved aortic remodeling in spontaneously hypertensive rats by inhibiting local renin-angiotensin system activity. Exp Ther Med. 16:4089–4099. 2018.PubMed/NCBI View Article : Google Scholar
24	U.S. National Institutes of Health. Laboratory animal welfare: Public Health Service policy on humane care and use of laboratory animals by awardee institutions; notice. Fed Regist. 50:19584–19585. 1985.PubMed/NCBI
25	Chi J, Meng L, Pan S, Lin H, Zhai X, Liu L, Zhou C, Jiang C and Guo H: Primary culture of rat aortic vascular smooth muscle cells: A New Method. Med Sci Monit. 23:4014–4020. 2017.PubMed/NCBI View Article : Google Scholar
26	Valero MS, Pereboom D, Barcelo-Batllory S, Brines L, Garay RP and Alda JO: Protein kinase A signalling is involved in the relaxant responses to the selective β-oestrogen receptor agonist diarylpropionitrile in rat aortic smooth muscle in vitro. J Pharm Pharmacol. 63:222–229. 2011.PubMed/NCBI View Article : Google Scholar
27	Yamaguchi T, Ida T, Hiraga M, Oishi K, Uchida MK and Echizen H: Effects of angiotensin II receptor blockers, angiotensin converting enzyme inhibitors, 3-hydroxy-3-methyl glutaryl (HMG) CoA reductase inhibitors, amlodipine and epalrestat on cultured basilar artery smooth muscle cell proliferation. Yakugaku Zasshi. 124:159–163. 2004.PubMed/NCBI View Article : Google Scholar
28	Kim JE and Choi HC: Losartan inhibits vascular smooth muscle cell proliferation through activation of AMP-activated protein kinase. Korean J Physiol Pharmacol. 14:299–304. 2010.PubMed/NCBI View Article : Google Scholar
29	Yamamura A, Ohara N and Tsukamoto K: Inhibition of excessive cell proliferation by calcilytics in idiopathic pulmonary arterial hypertension. PLoS One. 10(e0138384)2015.PubMed/NCBI View Article : Google Scholar
30	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Method. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar
31	Kobayashi-Torii M, Takahashi Y, Sunanaga J, Fujita M, Lee EY, Ichimaru Y, Fujita T, Kanmura Y and Kuwaki T: Possible participation of extracellular calcium-sensing receptor in blood presure regulation in rats. Brain Res. 1367:181–187. 2011.PubMed/NCBI View Article : Google Scholar
32	Smajilovic S, Hansen JL, Christoffersen TE, Lewin E, Sheikh SP, Terwilliger EF, Brown EM, Haunso S and Tfelt-Hansen J: Extracellular calcium sensing in rat aortic vascular smooth muscle cells. Biochem Biophys Res Commun. 348:1215–1223. 2006.PubMed/NCBI View Article : Google Scholar
33	Maillard MP, Tedjani A, Perregaux C and Burnier M: Calcium-sensing receptors modulate renin release in vivo and in vitro in the rat. J Hypertens. 27:1980–1997. 2009.PubMed/NCBI View Article : Google Scholar
34	Ström A, Franzén A, Wängnerud C, Knutsson AK, Heinegård D and Hultgårdh-Nilsson A: Altered vascular remodeling in osteopontin-deficient atherosclerotic mice. J Vasc Res. 41:314–322. 2004.PubMed/NCBI View Article : Google Scholar
35	Lai YM, Fukuda N, Su JZ, Suzuki R, Ikeda Y, Takagi H, Tahira Y and Kanmatsuse K: Novel mechanisms of the antiproliferative effects of amlodipine in vascular smooth muscle cells from spontaneously hypertensive rats. Hypertens Res. 25:109–115. 2002.PubMed/NCBI View Article : Google Scholar
36	Yi B, Cui J, Ning JN, Wang GS, Qian GS and Lu KZ: Over-expression of PKGIα inhibits hypoxia-induced proliferation, Akt activation, and phenotype modulation of human PASMCs: The role of phenotype modulation of PASMCs in pulmonary vascular remodeling. Gene. 492:354–360. 2012.PubMed/NCBI View Article : Google Scholar
37	Dickhout JG and Lee RM: Apoptosis in the muscular arteries from young spontaneously hypertensive rats. J Hypertens. 17:1413–1419. 1999.PubMed/NCBI View Article : Google Scholar
38	Song L, Gao LN, Wang J, Thapa S, Li Y, Zhong XB, Zhao HW, Xiang XR, Zhang FG and Ji P: Stromal Cell-derived factor-1αalleviates calcium-sensing receptor activation-mediated ischemia/reperfusion injury by inhibiting caspase-3/caspase-9-induced cell apoptosis in rat free flaps. Biomed Res Int. 2018(8945850)2018.PubMed/NCBI View Article : Google Scholar
39	Mcconkey DJ and Orrenius S: The role of calcium in the regulation of apoptosis. Biochem Biophys Res Commun. 239:357–366. 1997.PubMed/NCBI View Article : Google Scholar
40	McConkey DJ and Orrenius S: Signal transduction pathways to apoptosis. Trends Cell Biol. 4:370–375. 1994.PubMed/NCBI View Article : Google Scholar
41	Schiffrin EL and Touyz RM: From bedside to bench to bedside: Role of renin-angiotensin-aldosterone system in remodeling of resistance arteries in hypertension. Am J Physiol Heart Circ Physiol. 287:H435–H446. 2004.PubMed/NCBI View Article : Google Scholar
42	Gomes RA, Teodoro Ld, Lopes IC, Bersanetti PA, Carmona AK and Hial V: Angiotensin-converting enzyme in pericardial fluid: Comparative study with serum activity. Arq Bras Cardiol. 91:156–161. 2008.PubMed/NCBI(In English, Portuguese).
43	Intengan HD and Schiffrin EL: Vascular remodeling in hypertension: Roles of apoptosis, inflammation, and fibrosis. Hypertension. 38:581–587. 2001.PubMed/NCBI View Article : Google Scholar
44	deBlois D, Orlov SN and Hamet P: Apoptosis in cardiovascular remodeling-effect of medication. Cardiovasc Drugs Ther. 15:539–545. 2001.PubMed/NCBI View Article : Google Scholar
45	Tea BS, Der Sarkissian S, Touyz RM, Hamet P and deBlois D: Proapoptotic and growth-inhibitory role of angiotensin II type 2 receptor in vascular smooth muscle cells of spontaneously hypertensive rats in vivo. Hypertension. 35:1069–1073. 2000.PubMed/NCBI View Article : Google Scholar